Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Total Current Liabilities: 2017-2020

Historic Total Current Liabilities for Cogent Biosciences (COGT) over the last 4 years, with Dec 2020 value amounting to $13.1 million.

  • Cogent Biosciences' Total Current Liabilities fell 16.96% to $16.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was $16.7 million, marking a year-over-year decrease of 16.96%. This contributed to the annual value of $13.1 million for FY2020, which is 1.16% down from last year.
  • According to the latest figures from FY2020, Cogent Biosciences' Total Current Liabilities is $13.1 million, which was down 1.16% from $13.2 million recorded in FY2019.
  • Cogent Biosciences' Total Current Liabilities' 5-year high stood at $24.9 million during FY2018, with a 5-year trough of $11.2 million in FY2017.
  • Its 3-year average for Total Current Liabilities is $17.1 million, with a median of $13.2 million in 2019.
  • Per our database at Business Quant, Cogent Biosciences' Total Current Liabilities spiked by 122.92% in 2018 and then tumbled by 46.89% in 2019.
  • Cogent Biosciences' Total Current Liabilities (Yearly) stood at $11.2 million in 2017, then skyrocketed by 122.92% to $24.9 million in 2018, then tumbled by 46.89% to $13.2 million in 2019, then fell by 1.16% to $13.1 million in 2020.